Assignee
BIOVEC LLC
US·9 granted patents·75 citations·filing 2003–2011
Top patents by PatentIndex Score
9 records- 0194US7481998B2Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseasesBIOVEC LLC·Filed 2007·Granted Jan 27, 2009·14 cites·9 claims
- 0293US7501114B2Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseasesBIOVEC LLC·Filed 2007·Granted Mar 10, 2009·22 cites·20 claims
- 0390US7179459B2Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseasesBIOVEC LLC·Filed 2003·Granted Feb 20, 2007·21 cites·14 claims
- 0489US7687058B2Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseasesBIOVEC LLC·Filed 2008·Granted Mar 30, 2010·7 cites·18 claims
- 0588US7670597B2Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseasesBIOVEC LLC·Filed 2006·Granted Mar 2, 2010·7 cites·12 claims
- 0684US7803365B2Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseasesBIOVEC LLC·Filed 2007·Granted Sep 28, 2010·4 cites·14 claims
- 0767US7713522B2Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseasesBIOVEC LLC·Filed 2008·Granted May 11, 2010·0 cites·11 claims
- 0859US8367056B2In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectorsBIOVEC LLC·Filed 2011·Granted Feb 5, 2013·0 cites·8 claims
- 0958US8048410B2In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectorsBIOVEC LLC·Filed 2010·Granted Nov 1, 2011·0 cites·4 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →